Virasoft Corporation

Virasoft Corporation is a New York-based startup that specializes in developing artificial intelligence (AI) and digital pathology solutions for cancer diagnosis and research. With a slogan of Digital Pathology Workflow & AI Solutions, the company has been providing its services to pathology laboratories since 2019. Currently, their solutions are employed in over 20 institutions, processing around 400,000 cases yearly. Notably, their recent ₺2.80M Seed Round investment was secured on 30 December 2022 from Yıldız Tekno GSYO. The company's operations extend to Istanbul, Turkey, and their areas of interest span across AI, Biotechnology, Data Analytics, Enterprise Software, Health Care, and Clean Energy. Virasoft's extensive services allow for the curation of data, essential for the development of their deep-learning algorithms.